Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by COVID-19 pandemic impact, increasing demand for precision medicine, and increasing use of diagnostics.
The cell surface markers market is segmented as below:
By Application
- Disease diagnosis
- Research
- drug discovery
By Product
- Antibody
- PCR array
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the cell surface markers market covers the following areas:
- Cell surface markers market sizing
- Cell surface markers market forecast
- Cell surface markers market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary
The publisher recognizes the following companies as the key players in the global cell surface markers market: Abbott Laboratories, Abcam plc, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., Cell Signaling Technology Inc., Danaher Corp., DiaSorin SpA, F. Hoffmann La Roche Ltd., GenScript Biotech Corp., Grifols SA, IVD Medical Holding Ltd., Johnson and Johnson, PerkinElmer Inc., QIAGEN NV, Siemens Healthineers AG, Sysmex Corp., Thermo Fisher Scientific Inc., and Werfenlife SA.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is increased use of diagnostics in cancer detection.'
According to the report, one of the major drivers for this market is the COVID-19 pandemic impact.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Abcam plc
- Agilent Technologies Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- Cell Signaling Technology Inc.
- Danaher Corp.
- DiaSorin SpA
- F. Hoffmann La Roche Ltd.
- GenScript Biotech Corp.
- Grifols SA
- IVD Medical Holding Ltd.
- Johnson and Johnson
- PerkinElmer Inc.
- QIAGEN NV
- Siemens Healthineers AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Werfenlife SA